Allamand, A.; Noël-Duchesneau, L.; Ettelbruck, C.; Luna, E.D.; Lièvremont, D.; Grosdemange-Billiard, C.
MEP Pathway: First-Synthesized IspH-Directed Prodrugs with Potent Antimycobacterial Activity. Microorganisms 2026, 14, 215.
https://doi.org/10.3390/microorganisms14010215
AMA Style
Allamand A, Noël-Duchesneau L, Ettelbruck C, Luna ED, Lièvremont D, Grosdemange-Billiard C.
MEP Pathway: First-Synthesized IspH-Directed Prodrugs with Potent Antimycobacterial Activity. Microorganisms. 2026; 14(1):215.
https://doi.org/10.3390/microorganisms14010215
Chicago/Turabian Style
Allamand, Alizée, Ludovik Noël-Duchesneau, Cédric Ettelbruck, Edgar De Luna, Didier Lièvremont, and Catherine Grosdemange-Billiard.
2026. "MEP Pathway: First-Synthesized IspH-Directed Prodrugs with Potent Antimycobacterial Activity" Microorganisms 14, no. 1: 215.
https://doi.org/10.3390/microorganisms14010215
APA Style
Allamand, A., Noël-Duchesneau, L., Ettelbruck, C., Luna, E. D., Lièvremont, D., & Grosdemange-Billiard, C.
(2026). MEP Pathway: First-Synthesized IspH-Directed Prodrugs with Potent Antimycobacterial Activity. Microorganisms, 14(1), 215.
https://doi.org/10.3390/microorganisms14010215
